3 recruiting, 1 completed, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Bjorn H. Ebdrup: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project Severe Mental Illness, Schizophrenia Spectrum &Amp; Other Psychotic Disorders | Recruiting | Bjorn H. Ebdrup | 75 | 2025-01-01 | 2026-05-04 | |
| The Sub-Sero Study Pimavanserin 34 milligrams (MG) [Nuplazid] - Schizophrenia, Psychosis | Phase 2 | Withdrawn | Bjorn H. Ebdrup | 2024-12-01 | 2024-12-09 | |
| Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic Treatment in the Meta Care Clinic, Standard care with general practitioner and/or outpatient clinics - Severe Mental Disorder, Metabolic Complication | Not applicable | Recruiting | Bjorn H. Ebdrup | 84 | 2023-10-10 | 2026-01-08 |
| Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis Memantine, Placebo - Psychosis, Negative Symptoms With Primary Psychotic Disorder | Phase 1 | Recruiting | Bjorn H. Ebdrup | 46 | 2021-05-26 | 2024-12-09 |
| Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue Exenatide, Placebo - Obesity, Metabolic Syndrome X | Phase 3 | Completed | Bjorn H. Ebdrup | 45 | 2013-02-01 | 2015-06-24 |
Bipolar Disorder (2) · Mental Disorders (2) · Obesity (2) · Psychotic Disorders (2) · Schizophrenia (2) · Cardiovascular Diseases (1) · Drug-Related Side Effects and Adverse Reactions (1) · Metabolic Syndrome (1) · Motor Activity (1) · Overweight (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
Exenatide (1) · Memantine (1) · Standard of Care (1) · Therapeutics (1) · pimavanserin (1)
Denmark (4)
Bjorn H. Ebdrup, MD, Consultant,PhD, Professor, (1) · Olga B Baltzersen, MD (1)
PMID 24401727, PMID 27717222, PMID 28260235, PMID 32425802, PMID 35669271
2019 (1)